Literature DB >> 31300529

Neonatal Abstinence Syndrome and Associated Neonatal and Maternal Mortality and Morbidity.

Sarka Lisonkova1,2, Lindsay L Richter3, Joseph Ting4, Giulia M Muraca3, Qi Wen5, Azar Mehrabadi6, Sheona Mitchell-Foster3,7, Eugenia Oviedo-Joekes2,8, Janet Lyons3.   

Abstract

OBJECTIVES: We examined demographic characteristics and birth outcomes of infants with neonatal abstinence syndrome (NAS) and their mothers in Canada.
METHODS: This retrospective, population-based, descriptive cross-sectional study of mother-infant dyads included all singleton live births in Canada (excluding Quebec), from 2005-2006 to 2015-2016 (N = 2 881 789). Demographic characteristics, NAS, and neonatal and maternal morbidities were identified from delivery hospitalization data (including diagnostic codes). The main composite outcomes were maternal and neonatal mortality and/or severe morbidity, including death and potentially life-threatening conditions in the mother and the infant, respectively. Logistic regression yielded adjusted odds ratios (aORs) and 95% confidence intervals (CIs).
RESULTS: The study included 10 027 mother-infant dyads with NAS. The incidence of NAS increased from 0.20% to 0.51%. Maternal mortality was 1.99 vs 0.31 per 10 000 women in the NAS group versus the comparison group (aOR = 6.53; 95% CI: 1.59 to 26.74), and maternal mortality and/or severe morbidity rates were 3.10% vs 1.35% (aOR = 2.21; 95% CI: 1.97 to 2.49). Neonatal mortality was 0.12% vs 0.19% (aOR = 0.28; 95% CI: 0.15 to 0.53), and neonatal mortality and/or severe morbidity rates were 6.36% vs 1.73% (aOR = 2.27; 95% CI: 2.06 to 2.50) among infants with NAS versus without NAS.
CONCLUSIONS: NAS incidence increased notably in Canada between 2005-2006 and 2015-2016. Infants with NAS had elevated severe morbidity, and their mothers had elevated mortality and severe morbidity. These results highlight the importance of implementing integrated care services to support the mother-infant dyad during childbirth and in the postpartum period.
Copyright © 2019 by the American Academy of Pediatrics.

Entities:  

Year:  2019        PMID: 31300529     DOI: 10.1542/peds.2018-3664

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  7 in total

Review 1.  Targeted drug delivery for maternal and perinatal health: Challenges and opportunities.

Authors:  Anjali Sharma; Nirnath Sah; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  Adv Drug Deliv Rev       Date:  2021-08-26       Impact factor: 17.873

Review 2.  Intertwined disparities: Applying the maternal-infant dyad lens to advance perinatal health equity.

Authors:  Kimberly B Glazer; Jennifer Zeitlin; Elizabeth A Howell
Journal:  Semin Perinatol       Date:  2021-03-21       Impact factor: 3.311

3.  Non-pharmacological care for opioid withdrawal in newborns.

Authors:  Adrienne Pahl; Leslie Young; Madge E Buus-Frank; Lenora Marcellus; Roger Soll
Journal:  Cochrane Database Syst Rev       Date:  2020-12-21

4.  Incidence of Neonatal Abstinence Syndrome Epidemic and Associated Predictors in Nevada: A Statewide Audit, 2016-2018.

Authors:  Kavita Batra; Patricia Cruz; Chad L Cross; Neeraj Bhandari; Farooq Abdulla; Jennifer R Pharr; Mark P Buttner
Journal:  Int J Environ Res Public Health       Date:  2020-12-30       Impact factor: 3.390

5.  Estimating the impact of neonatal abstinence system interventions on Medicaid: an incremental cost analysis.

Authors:  Diana López-Soto; Paul M Griffin
Journal:  Subst Abuse Treat Prev Policy       Date:  2021-12-20

6.  Contribution of pharmaceutical drugs of dependence to the incidence of neonatal abstinence syndrome in Western Australia between 2003 and 2018.

Authors:  Erin A Kelty; Craig N Cumming; David B Preen
Journal:  Pharmacotherapy       Date:  2022-04-04       Impact factor: 6.251

7.  Enhanced H3K4 Trimethylation in TNF-α Promoter Gene Locus with Cell Apoptosis in the Ventral-Medial Striatum following Opioid Withdrawal of Neonatal Rat Offspring from Morphine-Addicted Mothers.

Authors:  Pei-Ling Wu; Jau-Ling Suen; Chun-Hwa Yang; Kuang-Che Kuo; Yu-Chen S H Yang; San-Nan Yang
Journal:  Mediators Inflamm       Date:  2021-06-16       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.